|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:12,789,751...113,558,310
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:13,533,770...42,791,750
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:28,875,650...52,200,160
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr18:52,539,763...63,933,058
|
|
|
Q |
Aia10 |
Adjuvant induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:75,788,062...101,769,107
|
|
Q |
Aia11 |
Adjuvant induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:60,781,426...86,533,673
|
|
Q |
Aia12 |
Adjuvant induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:38,281,509...83,281,509
|
|
Q |
Aia13 |
Adjuvant induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 2:76,539,322...77,991,361
|
|
Q |
Aia14 |
Adjuvant induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
|
|
Q |
Aia15 |
Adjuvant induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:17,004,598...62,004,598
|
|
Q |
Aia16 |
Adjuvant induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:59,238,038...104,238,038
|
|
Q |
Aia17 |
Adjuvant induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:81,737,938...126,737,938
|
|
Q |
Aia18 |
Adjuvant induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:8,736,635...53,736,635
|
|
Q |
Aia19 |
Adjuvant induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:66,978,955...107,211,142
|
|
Q |
Aia20 |
Adjuvant induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:37,565,079...82,565,079
|
|
Q |
Aia21 |
Adjuvant induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:9,831,541...54,831,541
|
|
Q |
Aia22 |
Adjuvant induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:1...34,266,636
|
|
Q |
Aia23 |
Adjuvant induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:11,766,535...32,331,607
|
|
Q |
Aia24 |
Adjuvant induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:52,847,908...73,690,657
|
|
Q |
Aia25 |
Adjuvant induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:50,909,196...60,781,426
|
|
Q |
Aia26 |
Adjuvant induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:38,281,509...83,281,509
|
|
Q |
Aia27 |
Adjuvant induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr20:2,892,597...26,381,954
|
|
Q |
Aia6 |
Adjuvant induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:66,978,955...107,211,142
|
|
Q |
Aia7 |
Adjuvant induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:37,565,079...82,565,079
|
|
Q |
Aia8 |
Adjuvant induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:9,831,541...54,831,541
|
|
Q |
Aia9 |
Adjuvant induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:11,766,535...32,331,607
|
|
Q |
Bss51 |
Bone structure and strength QTL 51 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 1:1...32,356,093
|
|
Q |
Bss53 |
Bone structure and strength QTL 53 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 1:43,284,731...118,944,897
|
|
Q |
Bss60 |
Bone structure and strength QTL 60 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 8:50,095,249...82,460,899
|
|
Q |
Bss66 |
Bone structure and strength QTL 66 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 1:11,481,312...82,174,945
|
|
Q |
Tcas1 |
Tongue tumor susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:2,316,121...47,316,121
|
|
Q |
Tcas10 |
Tongue tumor susceptibility QTL 10 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,297,439...76,297,439
|
|
Q |
Tcas2 |
Tongue tumor susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:192,485,903...199,050,587
|
|
Q |
Tcas3 |
Tongue tumor susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:10,814,170...91,360,527
|
|
Q |
Tcas4 |
Tongue tumor susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,622,561...42,337,007
|
|
Q |
Tcas5 |
Tongue tumor susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr19:9,977,753...39,654,489
|
|
Q |
Tcas6 |
Tongue tumor susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:92,948,896...144,267,916
|
|
Q |
Tcas8 |
Tongue tumor susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q |
Tcas9 |
Tongue tumor susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 6:1...37,618,905
|
|
Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:99,267,916...144,267,916
|
|
|
Q |
Bss52 |
Bone structure and strength QTL 52 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 1:1...32,356,093
|
|
Q |
Bss75 |
Bone structure and strength QTL 75 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr 8:30,848,154...82,460,899
|
|
Q |
Bss81 |
Bone structure and strength QTL 81 |
|
IDA |
|
RGD |
PMID:19113924 |
RGD:2312767 |
NCBI chr14:37,669,719...82,669,719
|
|